Related Experiment Video
Updated: Mar 14, 2026

Isolation of High Quality Murine Atrial and Ventricular Myocytes for Simultaneous Measurements of Ca2+ Transients and L-Type Calcium Current
Published on: November 3, 2020
Dyssynchronous calcium removal in heart failure-induced atrial remodeling
F Hohendanner1, J DeSantiago1, F R Heinzel1
1Department of Molecular Biophysics and Physiology, Rush University Medical Center, Chicago, Illinois.
Insights
Heart failure in atrial cells causes abnormal calcium removal, increasing arrhythmia risk. Inhibiting the sodium-calcium exchanger (NCX) normalizes calcium handling and reduces arrhythmias.
Area of Science:
- Cardiology
- Cell Physiology
- Biophysics
Background:
- Heart failure (HF) alters cardiac cell function.
- Calcium (Ca) handling is crucial for heart rhythm.
- Atrial myocytes in HF models exhibit impaired Ca removal.
Purpose of the Study:
- Investigate if spatial and temporal dyssynchrony of Ca removal, alongside increased Na/Ca exchange (NCX) activity, promotes arrhythmias in HF atrial myocytes.
- Determine the role of NCX in proarrhythmic Ca release in HF.
Main Methods:
- Used a rabbit left ventricular heart failure (HF) model.
- Measured Ca transient (CaT) decay kinetics in subsarcolemmal (SS) and central (CT) regions of atrial myocytes using confocal microscopy and Fluo-4.
- Quantified Ca removal dyssynchrony using the CV TAU metric.
- Assessed the impact of NCX inhibition on Ca waves and arrhythmias.
Main Results:
- HF atrial myocytes displayed accelerated but dyssynchronous Ca removal.
- Increased NCX activity in HF cells correlated with more spontaneous and arrhythmogenic Ca waves.
- NCX inhibition improved Ca removal synchrony (normalized CV TAU) and reduced Ca wave incidence in HF cells.
Conclusions:
- Accelerated and dyssynchronous diastolic Ca removal in HF atrial myocytes, driven by altered sarcoplasmic reticulum Ca-ATPase (SERCA) and NCX activity, increases arrhythmia susceptibility.
- NCX plays a significant role in mediating proarrhythmic Ca release and arrhythmias in HF atrial cells.
Abstract:
We tested the hypothesis that in atrial myocytes from a rabbit left ventricular heart failure (HF) model, spatial inhomogeneity and temporal dyssynchrony of Ca removal during excitation-contraction coupling together with increased Na/Ca exchange (NCX) activity generate a substrate for proarrhythmic Ca release. Ca removal occurs via Ca reuptake into the sarcoplasmic reticulum and extrusion via NCX exclusively in the cell periphery since rabbit atrial myocytes lack transverse tubules. Ca removal kinetics were assessed by the time constant τ of decay of local peripheral subsarcolemmal (SS) and central (CT) action potential (AP)-induced Ca transients (CaTs) recorded in confocal line scan mode (using Fluo-4). Spatial and temporal dyssynchrony of Ca removal was quantified by CV TAU, defined as the standard deviation of local τ along the transverse cell axis divided by mean τ. In normal cells CT CaT decline was slower compared with the SS domain, while in HF cells decline was accelerated, became equal in SS and CT regions, and a significant increase of CV TAU indicated an increased Ca removal dyssynchrony. In HF atrial cells NCX upregulation was accompanied by an overall higher incidence of spontaneous Ca waves and a higher propensity of arrhythmogenic Ca waves, defined as waves that triggered APs due to NCX-mediated membrane depolarization. NCX inhibition normalized CV TAU in HF atrial cells and decreased the propensity of Ca waves. In summary, HF atrial myocytes show accelerated but dyssynchronous diastolic Ca removal and altered sarcoplasmic reticulum Ca-ATPase (SERCA) and NCX activity that result in increased susceptibility to arrhythmia.
More Related Videos
10:53Isolation of Human Atrial Myocytes for Simultaneous Measurements of Ca2+ Transients and Membrane Currents
Published on: July 3, 2013
11:00Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes
Published on: September 18, 2017
Related Concept Videos
Heart Failure II: Pathophysiology
Cardiomyopathy II: Dilated Cardiomyopathy
Mechanism of Cardiac Arrhythmias
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Pathophysiology of Heart Failure